Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2017,NCI,5R01CA179062-03,,Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy,"SOTOMAYOR, EDUARDO",GEORGE WASHINGTON UNIVERSITY,DC,"$362,569"
Lymphoma,2017,NIEHS,5U13ES026496-02,,Childhood Leukemia International Consortium Scientific Annual Meetings,"METAYER, CATHERINE",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$15,000"
Lymphoma,2017,NCI,1K22CA207598-01,,The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis,"LI, YULIN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$188,379"
Lymphoma,2017,NIAID,5R01AI105114-04,,Viral Interface with an Interferon-Induced Gene,"REICH, NANCY",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$463,541"
Lymphoma,2017,NIAID,5R01AI072194-08,,Elucidation of Immunoglobulin Class Switch Recombination,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$439,750"
Lymphoma,2017,NIAID,5R01AI114556-03,,"Targeting Fnip1 to disrupt B cell development, metabolism, and transformation","IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$386,250"
Lymphoma,2017,NCI,5R01CA184187-03,,DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2017,NIAID,5R01AI114557-03,,Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$593,287"
Lymphoma,2017,NIGMS,5R01GM111741-03,,High-throughput informatics for antibodies,"MACCARTHY, THOMAS",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$266,488"
Lymphoma,2017,NIDCR,5R01DE025567-02,,Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid,"ZHOU, Z",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$385,000"
Lymphoma,2017,NCI,5F31CA183569-04,,The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis,"TAMEIRE, FEVEN",UNIVERSITY OF PENNSYLVANIA,PA,"$30,934"
Lymphoma,2017,NCI,5R01CA182461-04,,Defining the impact of clonal evolution on chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$362,378"
Lymphoma,2017,NCI,5R01CA164178-05,,A novel NKG2D-specific BiTE cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$336,150"
Lymphoma,2017,NIAID,5R01AI106393-05,,BH3-only protein targeting by HHV-8,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Lymphoma,2017,NCI,5F31CA192835-03,,Intratumoral Heterogeneity and Tumor Evolution in Lymphoma,"KASTENHUBER, EDWARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$44,044"
Lymphoma,2017,NIGMS,5R01GM073857-10,,Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides,"ENGELMAN, DONALD",YALE UNIVERSITY,CT,"$569,403"
Lymphoma,2017,NIAID,5R01AI108407-03,,Role of MHV68 miRNAs in latencyand pathogenesis,"TIBBETTS, SCOTT",UNIVERSITY OF FLORIDA,FL,"$396,236"
Lymphoma,2017,NCI,5R01CA183444-04,,Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$523,187"
Lymphoma,2017,NCI,5R21CA200420-02,,The effect of statins on B cell dysfunction in HIV infection,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$215,985"
Lymphoma,2017,NIAID,5R21AI122670-02,,Developing a new model for EBV-mediated T cell diseases,"PELANDA, ROBERTA",UNIVERSITY OF COLORADO DENVER,CO,"$233,250"
Lymphoma,2017,NCI,5R01CA172492-05,,Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma,"PASQUALUCCI, LAURA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$332,000"
Lymphoma,2017,NIAID,5R37AI037526-23,,Class Switch Recombination in B Lymphocytes,"NUSSENZWEIG, MICHEL",ROCKEFELLER UNIVERSITY,NY,"$423,750"
Lymphoma,2017,NCI,5R00CA183914-04,,A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment,"WAN, LIXIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$254,171"
Lymphoma,2017,NCI,5R01CA196266-02,,A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL,"PENICHET, MANUEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$502,591"
Lymphoma,2017,NCI,5R01CA190384-03,,The genomic pathogenesis of Follicular Lymphoma,"MALEK, SAMI",UNIVERSITY OF MICHIGAN,MI,"$541,994"
Lymphoma,2017,NCI,5R01CA194263-02,,Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders,"FANG, CAROLYN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$632,188"
Lymphoma,2017,NCI,5R01CA180758-04,,KSHV interactions with host inflammasome components,"CHANDRAN, BALA",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$63,355"
Lymphoma,2017,NCI,5P01CA094237-15,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$295,519"
Lymphoma,2017,NCI,5K22CA184308-03,,Dissecting Genetic and Epigenetic variation in the Cancer Regulome,"HODGES, EMILY",VANDERBILT UNIVERSITY,TN,"$157,854"
Lymphoma,2017,NIAID,5R21AI124172-02,,Rab7 and NF-kappaB in B cell activation and dysregulation,"XU, ZHENMING",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$187,213"
Lymphoma,2017,NCI,5P30CA008748-51,7551,Monoclonal Antibody,"WEIS-GARCIA, FRANCES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$308,192"
Lymphoma,2017,NCI,5R01CA165469-05,,Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,"BONDADA, SUBBARAO",UNIVERSITY OF KENTUCKY,KY,"$381,420"
Lymphoma,2017,NCI,5R01CA075922-21,,Rhesus HHV-8 homologue in AIDS-related malignancies,"WONG, SCOTT",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$794,238"
Lymphoma,2017,NCI,5R01CA180813-04,,Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Lymphoma,2017,NCI,5R01CA166144-06,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$327,938"
Lymphoma,2017,NIAID,5R01AI106676-04,,Epstein Barr virus antisense transcription,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2017,NCI,5R01CA168482-05,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2017,NCI,5UM1CA173642-05,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,260,718"
Lymphoma,2017,NCI,5R01CA091791-15,,Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$284,547"
Lymphoma,2017,NCI,2P30CA006516-52,5400,Program 6: Lymphoma and Myeloma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$43,077"
Lymphoma,2017,NCI,5R01CA166450-05,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$319,550"
Lymphoma,2017,NIGMS,1P20GM121288-01,6063,Project 1-Role of HERV-K Reactivation in AIDS-related Kaposi's Sarcoma,"QIN, ZHIQIANG",LSU HEALTH SCIENCES CENTER,LA,"$241,864"
Lymphoma,2017,NCI,5F30CA189433-03,,Investigating the function of MTBP in lymphoma,"PUCCETTI, MATTHEW",VANDERBILT UNIVERSITY,TN,"$6,135"
Lymphoma,2017,NIAID,5R21AI115313-02,,Targeting B Cell MicroRNA in Post-Transplant EBV-Associated B Cell Lymphoma,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$197,731"
Lymphoma,2017,NIAID,5R01AI124186-02,,RNA-directed targeting of AID in immunity and genomic integrity,"CHAUDHURI, JAYANTA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$428,500"
Lymphoma,2017,NCI,5R01CA193140-02,,Targeting the Ig-light chains with CAR-T cells in lymphoid tumors,"DOTTI, GIANPIETRO",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$569,255"
Lymphoma,2017,NIEHS,5R01ES021832-05,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$364,901"
Lymphoma,2017,NIAID,5R01AI018757-35,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Lymphoma,2017,NCI,5R01CA170023-05,,Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation,"ZHAO, BO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$393,163"
Lymphoma,2017,NCI,5K22CA188106-03,,Characterization of replication-mediated DNA damage in B lymphocytes,"BARLOW, JACQUELINE",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$162,000"
Lymphoma,2017,NCI,5R01CA119917-10,,Studying the role of KSHV-encoded miRNAs,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$301,913"
Lymphoma,2017,NCI,5R01CA186935-03,,Regulation of gamma delta T cell immunoediting by novel phosphoantigens,"WIEMER, ANDREW",UNIVERSITY OF CONNECTICUT STORRS,CT,"$377,822"
Lymphoma,2017,NIDCR,5R01DE025208-03,,KSHV latent infection replication,"KAYE, KENNETH",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Lymphoma,2017,NCI,1R01CA211963-01,,Ionizing radiation induced hematological malignancies,"ZHOU, DAOHONG",UNIV OF ARKANSAS FOR MED SCIS,AR,"$355,340"
Lymphoma,2017,NCI,5R01CA179363-04,,Molecular signature of inflammation,"MALARKANNAN, SUBRAMANIAM",MEDICAL COLLEGE OF WISCONSIN,WI,"$321,921"
Lymphoma,2017,NCI,5R21CA202525-02,,Targeting CXCR5 for angioimmunoblastic T-cell lymphoma,"LOLIS, ELIAS",YALE UNIVERSITY,CT,"$175,881"
Lymphoma,2017,NCI,1R01CA213138-01,,CD25-mediated feedback control of BCR-signaling and its oncogenic mimics,"MÜSCHEN, MARKUS",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$395,738"
Lymphoma,2017,NCI,1UH2CA206127-01A1,,Molecular diagnostic and prognostic signatures for PTCL,"IQBAL, JAVEED",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$205,470"
Lymphoma,2017,NIBIB,5R21EB020237-02,,Switchable Molecular Nanoprobes for Fast and Specific Intraoperative Diagnosis of Brain Tumors,"YAN, HAO",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$177,526"
Lymphoma,2017,NHLBI,5R01HL116452-05,,The role of the SF3B1 splicing factor in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$434,621"
Lymphoma,2017,NCI,5R01CA174462-05,,New Models and Treatments for AIDS-related Lymphoma,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$416,873"
Lymphoma,2017,NCI,5F31CA196209-03,,Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL,"RICKER, EDD",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$44,044"
Lymphoma,2017,NIAID,1R21AI128598-01,,Role of Siglec-10/G as a tumor suppressor in B-cells,"MACAULEY, MATTHEW",SCRIPPS RESEARCH INSTITUTE,CA,"$336,875"
Lymphoma,2017,NCI,5R01CA070723-20,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN-MADISON,WI,"$291,588"
Lymphoma,2017,NCI,5R01CA174794-05,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$605,760"
Lymphoma,2017,NIAID,5R01AI110328-04,,Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$378,130"
Lymphoma,2017,NCI,5R01CA184384-04,,Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$528,101"
Lymphoma,2017,NCI,5R01CA076167-14,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",AUGUSTA UNIVERSITY,GA,"$307,800"
Lymphoma,2017,NIAID,5R21AI124129-02,,Generation of a mouse expressing a photoactivatable Cre recombinase,"SCHWAB, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$211,875"
Lymphoma,2017,NIAID,5R01AI123420-02,,Targeting Epstein-Barr Virus super-enhancers,"ZHAO, BO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$443,750"
Lymphoma,2017,NIAID,5U01AI104342-05,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Lymphoma,2017,NCI,5R35CA200422-02,,Molecular Basis of KSHV oncogenesis,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$958,770"
Lymphoma,2017,NCI,5R01CA124332-11,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$304,095"
Lymphoma,2017,NCI,5R01CA137488-22,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$447,921"
Lymphoma,2017,NCI,5R01CA188561-04,,The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia,"OPAVSKY, RENE",UNIVERSITY OF FLORIDA,FL,"$348,844"
Lymphoma,2017,NIGMS,5K99GM117302-02,,A novel role for 53BP1 independent of damage that controls chromatin structure,"PEREIRA DA ROCHA, PEDRO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$90,000"
Lymphoma,2017,NCI,1R33CA212968-01,,LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics,"SINGH, ANKUR",CORNELL UNIVERSITY,NY,"$371,216"
Lymphoma,2017,NIAID,5U19AI109965-04,5822,Innate Recognition of Human Herpesviruses,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$415,379"
Lymphoma,2017,NCI,5R01CA177319-05,,The Role of NOTCH1 in the Pathogenesis of CLL.,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$358,315"
Lymphoma,2017,NCI,5R01CA172724-03,,Novel Strategies to Target Leukemia-Stromal Interactions,"HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$366,000"
Lymphoma,2017,NIDCR,5R01DE025804-02,,Role of IKK epsilon in KSHV/HHV8 associated malignancies,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$412,500"
Lymphoma,2017,NCI,5R01CA142698-08,,Molecular mechanism and relevance of microRNAs in DSB repair pathway choice,"CHOWDHURY, DIPANJAN",DANA-FARBER CANCER INST,MA,"$409,002"
Lymphoma,2017,NCI,5F30CA183263-03,,Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics,"KERN, HANNA",UNIVERSITY OF WASHINGTON,WA,"$38,095"
Lymphoma,2017,NCI,5R01CA184728-03,,Targeting Granzyme B to Separate GVH from GVL Responses,"CAO, XUEFANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$401,456"
Lymphoma,2017,NIDCR,5R01DE025994-02,,Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$437,944"
Lymphoma,2017,NIDCR,5R01DE025985-02,,KSHV Replication in Oral Epithelial Cells,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$392,500"
Lymphoma,2017,NCI,1R01CA204258-01A1,,Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors,"NICHOLS, HAZEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$675,579"
Lymphoma,2017,NCI,1R01CA201135-01A1,,Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma,"JAMES, RICHARD",SEATTLE CHILDREN'S HOSPITAL,WA,"$447,954"
Lymphoma,2017,NCI,5R01CA162411-05,,Novel monocyte effector function in CLL immune therapy,"TRIDANDAPANI, SUSHEELA",OHIO STATE UNIVERSITY,OH,"$319,550"
Lymphoma,2017,NCI,5R01CA204621-02,,Modulation of Host Cell Exosome Content and Function by EBV LMP1,"MECKES, DAVID",FLORIDA STATE UNIVERSITY,FL,"$341,410"
Lymphoma,2017,NCI,1R01CA203923-01A1,,IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis,"TARAKANOVA, VERA",MEDICAL COLLEGE OF WISCONSIN,WI,"$352,275"
Lymphoma,2017,NCI,2R01CA158073-06A1,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$380,000"
Lymphoma,2017,NCI,5R01CA176647-05,,Targeting stabilized mutant p53 protein,"MOLL, UTE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$356,514"
Lymphoma,2017,NCI,5R01CA193655-03,,Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$510,478"
Lymphoma,2017,NCI,5R01CA076445-16,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$384,750"
Lymphoma,2017,NCI,5P01CA174653-04,6845,Pathology,"BHAGAT, GOVIND",COLUMBIA UNIVERSITY,NY,"$188,903"
Lymphoma,2017,NCI,5P01CA174653-04,6841,The Role of CTIP in Lymphocyte Development and Lymphomagenesis,"ZHA, SHAN",COLUMBIA UNIVERSITY,NY,"$364,327"
Lymphoma,2017,NCI,5R21CA206104-02,,Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL),"WOOD, GARY",UNIVERSITY OF WISCONSIN-MADISON,WI,"$166,388"
Lymphoma,2017,NIDCR,5R01DE026003-02,,Targeting an immune kinase to purge KSHV latent infection,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$676,564"
Lymphoma,2017,NCI,5R01CA151898-07,,CRLF2 signaling in B-cell acute lymphoblastic leukemia,"WEINSTOCK, DAVID",DANA-FARBER CANCER INST,MA,"$392,969"
Lymphoma,2017,NIAID,5R01AI076183-15,,Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$507,585"
Lymphoma,2017,NCI,5R01CA063417-17,,PROLIFERATIVE EFFECTS OF HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$158,641"
Lymphoma,2017,NCI,2R01CA149707-06A1,,Investigating the functions of the miR-17~92 family of oncogenic microRNA clusters,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$385,650"
Lymphoma,2017,NCI,5R01CA164641-05,,Natural Killer Cell Regulation by PRDM1 and IRF4/8,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$321,210"
Lymphoma,2017,NCI,5R01CA177600-05,,Regulation of CARD11 signaling in normal and dysregulated lymphocyte development,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Lymphoma,2017,NCI,5F30CA183520-03,,Targeting CD37 and elucidating its role in B-cell malignancy,"BECKWITH, KYLE",OHIO STATE UNIVERSITY,OH,"$49,044"
Lymphoma,2017,NCI,5R01CA177292-05,,Targeted Therapy for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$536,708"
Lymphoma,2017,NCI,5R01CA187415-03,,MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma,"LI, YONG",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$448,485"
Lymphoma,2017,NCI,5R01CA155010-07,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$675,300"
Lymphoma,2017,NCI,5P30CA086862-17,7673,Program 4: Cancer Epidemiology and Population Science,"LYNCH, CHARLES",UNIVERSITY OF IOWA,IA,"$25,763"
Lymphoma,2017,NCI,5P01CA049605-28,5891,Immune Regulation in HCT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$1,151,709"
Lymphoma,2017,NCI,5P01CA049605-28,5892,Auto-lmmunotransplantation for Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$199,532"
Lymphoma,2017,NCI,5P01CA049605-28,5893,Memory CDS T Cells for GVL,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$150,530"
Lymphoma,2017,NCI,5P01CA049605-28,5894,Improving Graft-versus-Leukemia Alloimmunity against CLL,"MIKLOS, DAVID",STANFORD UNIVERSITY,CA,"$135,777"
Lymphoma,2017,NCI,5P01CA049605-28,5897,Administration and Clinical Trial Coordination,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$258,741"
Lymphoma,2017,NCI,5P01CA049605-28,5898,Biostatistics and Data Management,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$186,993"
Lymphoma,2017,NCI,5P01CA049605-28,5899,Molecular Diagnostics,"ZEHNDER, JAMES",STANFORD UNIVERSITY,CA,"$239,455"
Lymphoma,2017,NCI,5P01CA049605-28,5900,Cell Processing and Sample Distribution Laboratory,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$377,263"
Lymphoma,2017,NCI,5F30CA206343-02,,The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas,"COONEY, JEFFREY",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$32,244"
Lymphoma,2017,NCI,5P01CA174439-05,8216,Role of LANA-RBP-jk During Early KSHV Infection,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$341,337"
Lymphoma,2017,NCI,5P01CA174439-05,8218,Chromatin Regulation of KSHV Primary Infection,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$359,680"
Lymphoma,2017,NCI,5R01CA188286-03,,SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA,"PAYTON, JACQUELINE",WASHINGTON UNIVERSITY,MO,"$348,844"
Lymphoma,2017,NCI,5R21CA195431-02,,Role of Follicular Dendritic Cells in B lymphoma,"APGAR, JOHN",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$212,063"
Lymphoma,2017,NIAMS,1F31AR070094-01A1,,Uncovering Antigenic and Microbial Contributors to the Pathogenesis of Cutaneous T Cell Lymphoma,"FANOK, MELANIA",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$43,576"
Lymphoma,2017,NCI,5R01CA193541-03,,Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia,"KAY, NEIL",MAYO CLINIC ROCHESTER,MN,"$510,400"
Lymphoma,2017,NCI,1F31CA213668-01,,CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells,"KUHN, NICHOLAS",SLOAN-KETTERING INST CAN RESEARCH,NY,"$44,044"
Lymphoma,2017,NCI,5F31CA206236-02,,Computational Analysis of Subclonal Evolution in Chronic Lymphocytic Leukemia,"FAN, JEAN",HARVARD MEDICAL SCHOOL,MA,"$12,568"
Lymphoma,2017,NCI,5R01CA192928-03,,Dual targeting of XPO1 and BTK in B cell malignancies,"LAPALOMBELLA, ROSA",OHIO STATE UNIVERSITY,OH,"$512,016"
Lymphoma,2017,NCI,2R13CA124293-10,,Annual International Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$5,000"
Lymphoma,2017,NCI,5R01CA182947-04,,Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells,"FARAG, SHERIF",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$321,933"
Lymphoma,2017,NCI,5R01CA093606-15,,Regulation of EBV Latency by EBNA1,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$329,956"
Lymphoma,2017,NCI,1R01CA214046-01,,Targeted Therapies for Richters Transformation,"LAPALOMBELLA, ROSA",OHIO STATE UNIVERSITY,OH,"$452,551"
Lymphoma,2017,NCI,5R01CA129037-10,,Replicative Senescence as a Tumor Suppressive Mechanism,"CHANG, SANDY",YALE UNIVERSITY,CT,"$306,860"
Lymphoma,2017,NCI,5R01CA181319-04,,Targeting Stem-Cell Dependent Drug Resistance in Human MCL,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$313,723"
Lymphoma,2017,NIAID,5R01AI121300-02,,Non-coding RNAs in Gammaherpesvirus Infection and Disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$385,420"
Lymphoma,2017,NCI,5R01CA184922-04,,(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$553,684"
Lymphoma,2017,NIAID,5R01AI105000-05,,KSHV Lytic DNA Replication and its Control Mechanism,"VERMA, SUBHASH",UNIVERSITY OF NEVADA RENO,NV,"$356,575"
Lymphoma,2017,NCI,5R01CA187299-03,,Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma,"RUI, LIXIN",UNIVERSITY OF WISCONSIN-MADISON,WI,"$349,988"
Lymphoma,2017,NCI,5P01CA022443-40,6859,Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,"MERTZ, JANET",UNIVERSITY OF WISCONSIN-MADISON,WI,"$345,176"
Lymphoma,2017,NCI,5P01CA022443-40,6863,miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$392,337"
Lymphoma,2017,NCI,5R01CA185372-04,,(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies,"RICHARDS, KRISTY",CORNELL UNIVERSITY,NY,"$321,625"
Lymphoma,2017,NIAID,5R01AI109644-04,,Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di,"SUN, ZUOMING",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$420,000"
Lymphoma,2017,NCI,5R01CA203721-02,,Transforming the diagnosis and care of patients with CTCL using TCR sequencing,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$680,545"
Lymphoma,2017,NCI,5R01CA181699-04,,Investigating the roles of lncRNAs in cancer and development,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$419,643"
Lymphoma,2017,NIAID,5R21AI122068-02,,Antibody-based prophylactic EBV vaccine,"SNAPPER, CLIFFORD",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$192,510"
Lymphoma,2017,NCI,1P01CA214091-01,6349,"""Project 1"" KSHV-encoded Inc RNAs and alteration of host IncRNA expression","RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$241,215"
Lymphoma,2017,NCI,1P01CA214091-01,6350,"""Project 2"" Epstein-Barr virus LMP2 IncRNAs","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$330,828"
Lymphoma,2017,NCI,1P01CA214091-01,6351,"""Project 3"" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis","TIBBETTS, SCOTT",UNIVERSITY OF FLORIDA,FL,"$255,393"
Lymphoma,2017,NCI,1P01CA214091-01,6353,"""Core B"" Virus RNA-seq and Bioinformatics Core","FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$277,492"
Lymphoma,2017,NCI,5R01CA186775-04,,Development of a Small Molecule Inhibitor for KSHV LANA,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$394,250"
Lymphoma,2017,NCI,5P01CA125066-09,7158,Isolation Chemistry of Tropical Plants and Biological Evaluation,"KINGHORN, ALAN",OHIO STATE UNIVERSITY,OH,"$252,341"
Lymphoma,2017,NCI,5R01CA193624-03,,Development of a Novel Inducer for EBV Lytic Therapy,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$546,954"
Lymphoma,2017,NCI,5R01CA073507-19,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$372,677"
Lymphoma,2017,NCI,5F32CA203217-02,,Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis,"FERNANDEZ, MARIO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$60,990"
Lymphoma,2017,NCI,5R01CA183876-04,,Towards The Chemotherapy-Free Treatment of Follicular Lymphoma,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$475,801"
Lymphoma,2017,NCI,5F30CA196082-03,,Defining the role of mutant XPO1 in chronic lymphocytic leukemia,"HING, ZACHARY",OHIO STATE UNIVERSITY,OH,"$38,779"
Lymphoma,2017,NCI,5U01CA183012-04,,Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient,"ZAIA, JOHN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$312,304"
Lymphoma,2017,NCI,5R21CA206309-02,,"(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS","HARRIS, REUBEN",UNIVERSITY OF MINNESOTA,MN,"$182,192"
Lymphoma,2017,NCI,5R01CA206019-02,,"Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients","COZEN, WENDY",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$816,487"
Lymphoma,2017,NHLBI,5R01HL116217-05,,Engraftment and in vivo selection of HIV-protected stem cells,"KIEM, HANS-PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$523,418"
Lymphoma,2017,NIAID,5U19AI107810-05,8686,Study of Novel HHV8/KSHV Encoded Genes,"DAMANIA, BLOSSOM",UNIVERSITY OF NORTH CAROLINA SYSTEM,NC,"$405,042"
Lymphoma,2017,NCI,5P30CA023100-31,6336,Hematologic Malignancies,"LIPPMAN, SCOTT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$20,988"
Lymphoma,2017,NCI,5R01CA189806-04,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$541,564"
Lymphoma,2017,NIDDK,5K08DK100739-04,,The Intraepithelial T cell Response in Celiac Disease,"HAN, ARNOLD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$166,212"
Lymphoma,2017,NIAID,5R01AI113130-02,,New Therapeutics for Post-Transplant Lymphoproliferative Disorder,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$398,138"
Lymphoma,2017,NCI,5P01CA023766-38,6334,Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to,"O'REILLY, RICHARD",SLOAN-KETTERING INST CAN RESEARCH,NY,"$400,570"
Lymphoma,2017,NCI,5R01CA134451-08,,Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$234,254"
Lymphoma,2017,NCI,5R21CA210904-02,,Core Essential Genes in Primary Effusion Lymphoma Cell Lines,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$168,019"
Lymphoma,2017,NCI,5R01CA182905-04,,Protein-coding and non-coding RNA biomarkers for early detection of CLL,"CALIN, GEORGE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$534,545"
Lymphoma,2017,NCI,2P30CA006973-54,8084,Hematologic Malignancies and BMT Program - 02,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$55,302"
Lymphoma,2017,NIGMS,1SC1GM122648-01,,Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma,"MALLIKARATCHY, PRABODHIKA",HERBERT H. LEHMAN COLLEGE,NY,"$362,800"
Lymphoma,2017,NCI,5R01CA096500-15,,Role of KSHV viral proteins in signaling and pathogenesis,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$281,108"
Lymphoma,2017,NCI,1P01CA214278-01,8888,Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.,"PORTER, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$435,992"
Lymphoma,2017,NCI,5R42CA183197-03,,Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma,"MILLS, KEVIN","CYTEIR THERAPEUTICS, INC.",MA,"$961,015"
Lymphoma,2017,NIGMS,5R35GM118009-02,,Site-Specific Recombination in Human Health & Disease,"LIEBER, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$487,031"
Lymphoma,2017,NCI,2P01CA087497-16A1,5245,Core C - The Molecular Systems Pathology Core,"CORDON-CARDO, CARLOS",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$262,699"
Lymphoma,2017,NCI,5R01CA194547-03,,The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma,"ELEMENTO, OLIVIER",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$530,098"
Lymphoma,2017,NCI,5R01CA095318-13,,Role of B cells in murine gammaherpesvirus 68,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$368,305"
Lymphoma,2017,NCI,5P30CA013696-43,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$35,133"
Lymphoma,2017,NCI,5P30CA013696-43,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$95,447"
Lymphoma,2017,NCI,5U01CA194389-03,,Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma,"ALIZADEH, ARASH",STANFORD UNIVERSITY,CA,"$643,804"
Lymphoma,2017,NCI,5R01CA177734-05,,Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$329,925"
Lymphoma,2017,NCI,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$36,372"
Lymphoma,2017,NHLBI,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$26,039"
Lymphoma,2017,NIA,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$1,874"
Lymphoma,2017,NIAID,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$177,638"
Lymphoma,2017,NICHD,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$7,688"
Lymphoma,2017,NIDA,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$18,461"
Lymphoma,2017,NIDDK,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$4,864"
Lymphoma,2017,NIGMS,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$4,864"
Lymphoma,2017,NIMH,5P30AI027757-30,7315,HIV-Associated Malignancies (HIVAM),"CASPER, COREY",UNIVERSITY OF WASHINGTON,WA,"$18,194"
Lymphoma,2017,NCI,5K08CA172215-05,,The role of GATA-3 in T-cell lymphomas,"WILCOX, RYAN",UNIVERSITY OF MICHIGAN,MI,"$178,618"
Lymphoma,2017,NCI,5R01CA206476-02,,(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection,"CHIAO, ELIZABETH",BAYLOR COLLEGE OF MEDICINE,TX,"$772,521"
Lymphoma,2017,NCI,5K24CA184039-04,,Molecularly Targeted Therapy for Lymphoma,"GOPAL, AJAY",UNIVERSITY OF WASHINGTON,WA,"$172,224"
Lymphoma,2017,NCI,5K23CA184279-04,,Molecular determinants of prognosis in limited-stage follicular lymphoma,"LOUISSAINT, ABNER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$140,263"
Lymphoma,2017,NIAID,5R21AI122035-02,,Role of Nuclear Lamina in the epigenetic regulation of Epstein-Barr Virus Infection,"TEMPERA, ITALO",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$195,000"
Lymphoma,2017,NCI,5R01CA197801-03,,Identification of Loci Modifying Atm Lymphomagenesis,"WEIL, MICHAEL",COLORADO STATE UNIVERSITY,CO,"$343,463"
Lymphoma,2017,NCI,5K08CA191019-04,,The Role of ZEB1 Mutations in Cutaneous T Cell Lymphoma,"CHOI, JAEHYUK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$152,388"
Lymphoma,2017,NCI,1K99CA215307-01,,Glycine metabolism in cancer,"DUCKER, GREGORY",PRINCETON UNIVERSITY,NJ,"$99,004"
Lymphoma,2017,NCI,5R01CA170006-06,,Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme,"GHOSH, ASISH",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$305,069"
Lymphoma,2017,NCI,5F30CA189740-04,,Alternative End-Joining in DNA Repair and Chromosomal Translocations,"KUMAR, VIPUL",HARVARD MEDICAL SCHOOL,MA,"$49,044"
Lymphoma,2017,NCI,5R01CA130995-10,,"Replication Licensing in Genome Stability, Cancer and Aging","PRUITT, STEVEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$324,743"
Lymphoma,2017,NCI,5R01CA163910-06,,TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM,"HU, CHIH-CHI",WISTAR INSTITUTE,PA,"$380,146"
Lymphoma,2017,NCI,5R01CA197945-03,,The role of RHOA G17V mutation in peripheral t-cell lymphomas,"PALOMERO, TERESA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$366,000"
Lymphoma,2017,NCI,5R01CA140337-07,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$371,732"
Lymphoma,2017,NCI,5R01CA206404-02,,Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.,"WONG, SCOTT",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$1,555,244"
Lymphoma,2017,NCI,5R01CA086065-18,,"HSC Diversity, in aging, ontogeny, and transformation","WEISSMAN, IRVING",STANFORD UNIVERSITY,CA,"$410,288"
Lymphoma,2017,NIAMS,5R01AR063962-05,,CTCL immunobiology: lessons from alemtuzumab,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$366,977"
Lymphoma,2017,NCI,5U01CA166905-05,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$915,659"
Lymphoma,2017,NCI,5U01CA195568-03,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$2,248,270"
Lymphoma,2017,NIDCR,5R01DE024971-03,,Platform technology for detection of cancer-associated viruses in HIV patients,"DEMIRCI, UTKAN",STANFORD UNIVERSITY,CA,"$423,242"
Lymphoma,2017,NCI,1R21CA205106-01A1,,A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies,"OGEMBO, JAVIER",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$234,992"
Lymphoma,2017,NCI,5F30CA203292-02,,"Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies","SWAROOP, ALOK",UNIVERSITY OF FLORIDA,FL,"$38,371"
Lymphoma,2017,NCI,5P01CA016038-43,7371,"Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA","MILLER, I.",YALE UNIVERSITY,CT,"$197,935"
Lymphoma,2017,NCI,5P01CA016038-43,7373,"Project 3, Steitz: Viral Noncoding RNAs and Cell Transformation","STEITZ, JOAN",YALE UNIVERSITY,CT,"$123,787"
Lymphoma,2017,NCI,5R01CA187799-03,,Role of FOXP1 and WNT signaling in B-cell Lymphoma,"MAJOR, MICHAEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$307,500"
Lymphoma,2017,NCI,5R01CA196703-03,,Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma,"CHIARLE, ROBERTO",BOSTON CHILDREN'S HOSPITAL,MA,"$404,888"
Lymphoma,2017,NCI,5R01CA201309-02,,How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$347,168"
Lymphoma,2017,NCI,5R01CA187040-05,,Targeting SIRT1 in Mantle Cell Lymphoma,"SETO, EDWARD",GEORGE WASHINGTON UNIVERSITY,DC,"$274,620"
Lymphoma,2017,NCI,5R01CA202712-02,,Risk factors for molecular subtypes of NHL a prospective evaluation,"WANG, SOPHIA",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$830,007"
Lymphoma,2017,NCI,5P01CA190193-03,8720,Project 1: Direct & Repeated pO2 Measurements for Cancer using EPR with Carbon Pa,"KUPPUSAMY, PERIANNAN",DARTMOUTH COLLEGE,NH,"$476,425"
Lymphoma,2017,NCI,5R21CA209107-02,,Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma,"FUSCHIOTTI, PATRIZIA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$167,831"
Lymphoma,2017,NCI,5K24CA208132-02,,Mentored Patient Oriented Research in Lymphoma,"FLOWERS, CHRISTOPHER",EMORY UNIVERSITY,GA,"$164,375"
Lymphoma,2017,NCI,1R01CA216273-01,,(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$701,924"
Lymphoma,2017,NCI,5R21CA202104-02,,Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling,"WANG, MICHAEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Lymphoma,2017,NCI,5UH2CA202637-02,,Smartphone for molecular cancer diagnostic in Africa,"WEISSLEDER, RALPH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$491,375"
Lymphoma,2017,NCI,1R01CA208352-01A1,,Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma,"WANG, XINJIANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$390,710"
Lymphoma,2017,NCI,5R01CA197870-03,,Improving BTK Directed Therapy for CLL,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$352,275"
Lymphoma,2017,RMAP,5K01ES025431-05,,The role of epigenetic heterogeneity in CLL evolution,"LANDAU, DAN",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$187,920"
Lymphoma,2017,NCI,5R01CA207513-02,,Role of KLHL6 inactivation in mature B-cell malignancies,"BUSINO, LUCA",UNIVERSITY OF PENNSYLVANIA,PA,"$368,288"
Lymphoma,2017,NCI,5R01CA203836-02,,Monocyte promotion of therapy resistance by immune and non-immune mechanisms,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$363,713"
Lymphoma,2017,NCI,5R44CA153474-03,,Virus-targeted therapeutic for EBV-Associated Malignancies,"PERRINE, SUSAN","PHOENICIA BIOSCIENCES, INC.",MA,"$519,583"
Lymphoma,2017,NCI,5R01CA206462-02,,SIRT2 Inhibitors for the Treatment of B-cell Lymphoma,"SIMON, JULIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$574,754"
Lymphoma,2017,NCI,5R01CA200703-02,,Genetic Epidemiology of non-Hodgkin Lymphoma,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$662,837"
Lymphoma,2017,NCI,5R01CA188794-04,,Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2017,NCI,5P30CA091842-16,6313,Hematopoietic Development and Malignancy (Project-002),"EBERLEIN, TIMOTHY",WASHINGTON UNIVERSITY,MO,"$64,408"
Lymphoma,2017,NCI,5R01CA161151-05,,Lig4R278H contribution to HSC and IgH class switching defects and malignancies,"YAN, CATHERINE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$381,305"
Lymphoma,2017,NCI,5R21CA202358-02,,Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses,"CAO, XUEFANG",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$189,334"
Lymphoma,2017,NCI,5F30CA210539-02,,Epigenetic activity of normal and cancer-associated mutant H1 linker histones,"HEALTON, SEAN","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$44,044"
Lymphoma,2017,NCI,5P30CA016086-41,8627,EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020),"DEES, ELIZABETH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$281,916"
Lymphoma,2017,NCI,5R21CA209341-02,,Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer,"FRUMAN, DAVID",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$197,737"
Lymphoma,2017,NIGMS,5R01GM106067-04,,DNA-carbon Assemblies for Multispectral Imaging,"KOOL, ERIC",STANFORD UNIVERSITY,CA,"$303,533"
Lymphoma,2017,NLM,1R21LM012395-01A1,,Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations,"EDWARDS, JOHN",WASHINGTON UNIVERSITY,MO,"$220,064"
Lymphoma,2017,NIGMS,5R01GM095606-07,,Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$298,000"
Lymphoma,2017,NCI,5R01CA114536-12,,TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$458,731"
Lymphoma,2017,NCI,5R01CA190628-03,,Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing,"FANG, BINGLIANG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$514,090"
Lymphoma,2017,NCI,5F31CA210429-02,,WDR5 as a Critical Co-Factor for MYC,"FOSHAGE, AUDRA",VANDERBILT UNIVERSITY,TN,"$28,716"
Lymphoma,2017,NIDDK,5R01DK067180-13,,Innate and adaptive immunity in celiac disease,"JABRI, BANA",UNIVERSITY OF CHICAGO,IL,"$531,480"
Lymphoma,2017,NCI,5R01CA139083-09,,Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$370,554"
Lymphoma,2017,NCI,5R01CA187109-04,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$492,647"
Lymphoma,2017,NCI,5R35CA197706-03,,Cancer Gene Discovery to Identify Targetable Targets,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$924,000"
Lymphoma,2017,NCI,5R01CA187492-04,,MALT1 Targeted Therapy for B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2017,NCI,5R33CA191159-03,,Using Adductomics to Characterize Exposures to Carcinogens,"RAPPAPORT, STEPHEN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$379,613"
Lymphoma,2017,NIAID,5R33AI116205-04,,"Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin","HENRICH, TIMOTHY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$403,568"
Lymphoma,2017,NCI,5P01CA180779-05,8771,Roles of the K3 and K5 in KSHV Persistence and Pathogenesis,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$339,204"
Lymphoma,2017,NCI,5P01CA180779-05,8772,Roles of Nucleotide Metabolic Control in KSHV Persistence,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$339,204"
Lymphoma,2017,NCI,5P01CA180779-05,8776,Core Director: Hye-Ra-Lee,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$140,496"
Lymphoma,2017,NHLBI,5R01HL114564-05,,Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes,"SAVOLDO, BARBARA",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$447,090"
Lymphoma,2017,NCI,5K22CA193674-03,,Lymphoma monocyte crosstalk: mechanisms of chemo-immunotherapy resistance,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$146,520"
Lymphoma,2017,NCI,7R01CA201380-02,,Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation,"GREEN, MICHAEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$356,616"
Lymphoma,2017,NCI,5R35CA210105-02,,From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$960,000"
Lymphoma,2017,NCI,5F30CA210518-02,,Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML,"DENG, LISA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$36,469"
Lymphoma,2017,NIAAA,5R01AA024770-02,,"A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.","FERRARI, PIETRO",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$494,761"
Lymphoma,2017,NCI,5R01CA161026-07,,Targetable Immune Evasion Pathways in Hodgkin Lymphoma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$373,399"
Lymphoma,2017,NIAID,1F30AI131496-01,,Dissecting the role of HVEM and BTLA in constraining the germinal center B cell response,"MINTZ, MICHELLE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$35,548"
Lymphoma,2017,NCI,5P01CA100730-14,5163,Core C: Animal Models,"NIEWIESK, STEFAN",OHIO STATE UNIVERSITY,OH,"$306,747"
Lymphoma,2017,NCI,5P01CA100730-14,5167,Project 4: Tumorigenic Effects of Tax,"RATNER, LEE",OHIO STATE UNIVERSITY,OH,"$436,430"
Lymphoma,2017,NCI,1F31CA217004-01,,Elucidating the mechanism of anti-GSK3 adjuvant therapy for Myc-driven lymphomas,"HARRINGTON, COLLEEN",UNIVERSITY OF PENNSYLVANIA,PA,"$44,044"
Lymphoma,2017,NCI,5P01CA165997-05,8409,Micro-RNA-dependent regulation of the UPR,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$310,156"
Lymphoma,2017,NCI,5P01CA165997-05,8411,Role of the UPR in myc-induced tumorigenesis,"KOUMENIS, CONSTANTINOS",UNIVERSITY OF PENNSYLVANIA,PA,"$260,995"
Lymphoma,2017,NCI,5P01CA165997-05,8412,"UPR, interferon signaling and tumorigenesis","FUCHS, SERGE",UNIVERSITY OF PENNSYLVANIA,PA,"$279,914"
Lymphoma,2017,NIAID,5R01AI045073-19,,Chemokines and Lymphoid Tissue Organization and Function,"CYSTER, JASON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$356,625"
Lymphoma,2017,NCI,1R01CA210250-01A1,,BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma,"BHALLA, KAPIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$390,134"
Lymphoma,2017,NCI,5R01CA184137-03,,Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy,"ALMASAN, ALEXANDRU",CLEVELAND CLINIC LERNER COM-CWRU,OH,"$362,569"
Lymphoma,2017,NCI,5R01CA076287-18,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"GREEN, DAMIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$379,044"
Lymphoma,2017,NCI,5R01CA195732-02,,The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy,"LICHT, JONATHAN",UNIVERSITY OF FLORIDA,FL,"$348,844"
Lymphoma,2017,NCI,5R01CA182736-05,,MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$699,439"
Lymphoma,2017,NCI,5R01CA197844-03,,Phosphatase activation as therapeutic strategy for Chronic lymphocyic leukemia,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$437,656"
Lymphoma,2017,NCI,5R01CA190860-03,,Pharmacological Blockage of XBP-1s Expression in Cancer,"DEL VALLE, JUAN",UNIVERSITY OF SOUTH FLORIDA,FL,"$453,625"
Lymphoma,2017,NCI,5R35CA197734-03,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$910,045"
Lymphoma,2017,NCI,5R01CA163217-07,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$342,759"
Lymphoma,2017,NCI,5R01CA197120-03,,Predicting clinical outcome in individuals with small CLL B cell clones,"KAY, NEIL",MAYO CLINIC ROCHESTER,MN,"$605,286"
Lymphoma,2017,NCI,5U54CA190152-04,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$251,154"
Lymphoma,2017,NCI,5U54CA190152-04,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$198,456"
Lymphoma,2017,NCI,5K23CA178183-05,,Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$173,232"
Lymphoma,2017,NCI,5R01CA190696-04,,A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose,"SCHATZ, JONATHAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$299,009"
Lymphoma,2017,FIC,5U54CA190146-04,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$7,664"
Lymphoma,2017,NCI,5U54CA190146-04,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$105,496"
Lymphoma,2017,NCI,5R01CA136895-09,,Understanding the context-dependent roles of mutations in lymphoma.,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$286,200"
Lymphoma,2017,NCI,5R00CA175181-04,,The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis,"SKALSKY, REBECCA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$249,000"
Lymphoma,2017,NCI,5K22CA197014-02,,Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma,"YANG, YIBIN",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$194,616"
Lymphoma,2017,NCI,5R01CA136551-09,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$560,424"
Lymphoma,2017,NCI,1R41CA210669-01A1,,Osteopontin-targeted therapy for primary CNS lymphoma,"COPLAND, JOHN","MODULATION THERAPEUTICS, INC.",WV,"$283,986"
Lymphoma,2017,NCI,5P01CA078902-19,5395,Project 3: Stem Cell Allografts for Lymphoid Malignancies,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$257,616"
Lymphoma,2017,NCI,5P01CA078902-19,7384,Program Integration and management,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$18,647"
Lymphoma,2017,NCI,5R44CA144104-05,,Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma,"KLINGHOFFER, RICHARD","PRESAGE BIOSCIENCES, INC.",WA,"$1,002,741"
Lymphoma,2017,NCI,5K99CA208017-02,,Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT),"ELGAMAL, DALIA",OHIO STATE UNIVERSITY,OH,"$103,394"
Lymphoma,2017,NCI,5P01CA206978-02,5148,"Discovery of clinically distinct CLL subgroups by integrative mapping of large-scale CLL genetic, expression and clinical data","GETZ, GAD","BROAD INSTITUTE, INC.",MA,"$341,388"
Lymphoma,2017,NCI,5P01CA206978-02,5149,CLL  clonal  evolution  and  the  development  of  therapy-driven  resistance,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$370,572"
Lymphoma,2017,NCI,5R35CA197353-02,,Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$909,837"
Lymphoma,2017,NCI,1R44CA210848-01A1,,Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma,"STRAUBE, RICHARD","SOLIGENIX, INC.",NJ,"$750,000"
Lymphoma,2017,RMAP,1DP2AI136599-01,,Identifying Mechanisms Governing T Cell Diversity,"CHOI, JAEHYUK",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$2,370,000"
Lymphoma,2017,NHLBI,5R01HL130539-02,,STOP-CA: Statins to prevent Cardiotoxicity from Anthracyclines,"NEILAN, TOMAS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$619,549"
Lymphoma,2017,NCI,5R01CA208398-02,,CAR-T cell control through orthogonal antibody-based switches,"YOUNG, TRAVIS",CALIFORNIA INSTITUTE/BIOMEDICAL RESEARCH,CA,"$411,782"
Lymphoma,2017,NCI,5UM1CA121947-11,,AIDS Malignancy Consortium (AMC),"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$22,965,613"
Lymphoma,2017,OD,5UM1CA121947-11,,AIDS Malignancy Consortium (AMC),"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$301,643"
Lymphoma,2017,NCI,5R01CA192970-02,,Lipoxins and aspirin triggered lipoxins in KSHV latency and pathogenesis,"SHARMA-WALIA, NEELAM",ROSALIND FRANKLIN UNIV OF MEDICINE & SCI,IL,"$356,850"
Lymphoma,2017,NCI,5K23CA212271-02,,Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies,"STEPHENS, DEBORAH",UNIVERSITY OF UTAH,UT,"$180,360"
Lymphoma,2017,NCI,5K99CA212198-02,,Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus,"LEE, CHANG LUNG",DUKE UNIVERSITY,NC,"$116,127"
Lymphoma,2017,NCI,5K99CA212276-02,,Role of histone demethylated LSD1 as an epigenetic dependency in lymphoma,"CHATZI, KATERINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$148,904"
Lymphoma,2017,NCI,2P50CA126752-11,8609,Administrative Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$208,820"
Lymphoma,2017,NCI,2P50CA126752-11,8610,Clinical & Biostats Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$223,665"
Lymphoma,2017,NCI,2P50CA126752-11,8611,Cell &Vector Core,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$463,752"
Lymphoma,2017,NCI,2P50CA126752-11,8612,Biospecimen and Pathology Core,"SHEEHAN, ANDREA",BAYLOR COLLEGE OF MEDICINE,TX,"$427,224"
Lymphoma,2017,NCI,2P50CA126752-11,8613,T cell therapy targeting multiple tumor antigens in lymphoma,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$388,160"
Lymphoma,2017,NCI,2P50CA126752-11,8614,CAR T cell therapy for T cell lymphoma,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$369,369"
Lymphoma,2017,NCI,2P50CA126752-11,8615,Overcoming Tumor Evasion in EBV+ve Lymphomas,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$380,727"
Lymphoma,2017,NCI,2P50CA126752-11,8616,Immunotherapy of B cell lymphoma with  NK-T cells,"METELITSA, LEONID",BAYLOR COLLEGE OF MEDICINE,TX,"$363,790"
Lymphoma,2017,NCI,2P50CA126752-11,8617,Developmental Research Program,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$141,934"
Lymphoma,2017,NCI,2P50CA126752-11,8618,Career Enhancement Program,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$130,216"
Lymphoma,2017,NIDCR,5DP5OD023118-02,,Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression,"DEKOSKY, BRANDON",UNIVERSITY OF KANSAS LAWRENCE,KS,$1
Lymphoma,2017,RMAP,5DP5OD023118-02,,Comprehensive analysis of human adaptive immune receptors to elucidate correlates of Epstein-Barr virus disease suppression,"DEKOSKY, BRANDON",UNIVERSITY OF KANSAS LAWRENCE,KS,"$369,644"
Lymphoma,2017,NCI,2P50CA097274-16,5214,Administration Core,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$187,251"
Lymphoma,2017,NCI,2P50CA097274-16,5215,Core B: Biospecimens,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$264,444"
Lymphoma,2017,NCI,2P50CA097274-16,5216,Core C: Biostatistics and Bioinformatics,"SMITH, BRIAN",UNIVERSITY OF IOWA,IA,"$224,741"
Lymphoma,2017,NCI,2P50CA097274-16,5217,Core D: Clinical,"HABERMANN, THOMAS",MAYO CLINIC ROCHESTER,MN,"$214,193"
Lymphoma,2017,NCI,2P50CA097274-16,5218,Project 1: Activating Phagocytic Macrophages in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",MAYO CLINIC ROCHESTER,MN,"$259,996"
Lymphoma,2017,NCI,2P50CA097274-16,5219,Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$252,394"
Lymphoma,2017,NCI,2P50CA097274-16,5220,Project 3: Targeting Tumor Metabolism in Lymphoma,"WITZIG, THOMAS",MAYO CLINIC ROCHESTER,MN,"$267,251"
Lymphoma,2017,NCI,2P50CA097274-16,5221,Project 4: Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$450,776"
Lymphoma,2017,NCI,2P50CA097274-16,5222,Developmental Research Program,"LENTZ, STEVEN",UNIVERSITY OF IOWA,IA,"$165,184"
Lymphoma,2017,NCI,2P50CA097274-16,5223,Career Enhancement Program,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$88,770"
Lymphoma,2017,NCI,5P30CA124435-10,7150,Lymphoma & Leukemia Research Program (Project-007),"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$32,997"
Lymphoma,2017,NCI,5P01CA019014-38,7901,Project 2 - Membrane trafficking in EBV malignancies:  Implication of deubiquitinase UCH-L1,"PAGANO, JOSEPH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$317,029"
Lymphoma,2017,NCI,5P01CA019014-38,7902,Project 3 - Modulation of host cell biology by KSHV,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$301,307"
Lymphoma,2017,NCI,5P01CA019014-38,7903,Project 4 - Study of KSHV Carcinogenesis,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$303,916"
Lymphoma,2017,NCI,5P30CA014089-42,8288,Molecular Genetics Research Program (Project-001),"LIEBER, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$61,951"
Lymphoma,2017,NCI,5P30CA016520-41,4005,Melanoma and Cutaneous Malignancies Research Program,"SCHUCHTER, LYNN",UNIVERSITY OF PENNSYLVANIA,PA,"$73,099"
Lymphoma,2017,NCI,5P30CA016520-41,8007,Hematologic Malignancies Research Program,"STADTMAUER, EDWARD",UNIVERSITY OF PENNSYLVANIA,PA,"$73,099"
Lymphoma,2017,NCI,1UH2CA217847-01,,Development of Mantle Cell Lymphoma Proliferation Signature Assay,"RIMSZA, LISA",MAYO CLINIC ARIZONA,AZ,"$198,578"
Lymphoma,2017,NCI,1R01CA217934-01,,(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment,"ST CLAIR, DARET",UNIVERSITY OF KENTUCKY,KY,"$455,149"
Lymphoma,2017,NCI,1R01CA219960-01,,PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma,"LIN, YI",MAYO CLINIC ROCHESTER,MN,"$545,997"
Lymphoma,2017,NCI,1K08CA219473-01,,Rational Translation of EZH2 Targeted Therapy in Germinal Center B-cell Lymphoma,"ROTH, LISA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$171,180"
Lymphoma,2017,NCI,1K08CA218460-01,,Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas,"MURGA-ZAMALLOA, CARLOS",UNIVERSITY OF MICHIGAN,MI,"$106,531"
Lymphoma,2017,NIEHS,1R35ES028303-01,,Mechanism of Eukaryotic Environmental Mutagenesis,"WALKER, GRAHAM",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$556,500"
Lymphoma,2017,NLM,1R21LM012618-01,,Bayesian Generative Methods for Extracting and Modeling Relations in EHR Narratives,"LUO, YUAN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$208,272"
Lymphoma,2017,NIAID,1R21AI133050-01,,Analysis of Mbd4 function during the generation of Ig diversity,"KENTER, AMY",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$239,850"
Lymphoma,2017,NHLBI,1R15HL135695-01A1,,Gfi1-mediated inhibition of the cytostatic effect of TGFβ in the hematopoietic system,"DONG, FAN",UNIVERSITY OF TOLEDO,OH,"$448,500"
Lymphoma,2017,NCI,3R01CA076167-14S1,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",AUGUSTA UNIVERSITY,GA,"$24,361"
Lymphoma,2017,NCI,3P30CA086862-17S1,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$114,375"
Lymphoma,2017,NCI,3P30CA086862-17S2,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$125,000"
Lymphoma,2017,NCI,3UM1CA173642-05S1,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$56,922"
Lymphoma,2017,NCI,3UM1CA173642-05S2,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$165,708"
Lymphoma,2017,NCI,3U01CA195568-03S1,,The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study,"CERHAN, JAMES",MAYO CLINIC ROCHESTER,MN,"$14,960"
Lymphoma,2017,NCI,3R35CA197734-03S1,,Targeted Therapy for Leukemia,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$64,960"
Lymphoma,2017,NCI,1R03CA219760-01,,Grail-targeting breaks the immune tolerance to melanoma,"NURIEVA, ROZA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$80,000"
Lymphoma,2017,NCI,1R01CA212162-01A1,,Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma,"NOVAK, ANNE",MAYO CLINIC ROCHESTER,MN,"$667,561"
Lymphoma,2017,NIAID,1R01AI127642-01A1,,Targeting of somatic hypermutation in the genome,"SCHATZ, DAVID",YALE UNIVERSITY,CT,"$417,987"
Lymphoma,2017,NCI,1R21CA220147-01,,Single-cell analysis of tumor-microenvironment interactions in follicular lymphoma,"KHARCHENKO, PETER",HARVARD MEDICAL SCHOOL,MA,"$154,207"
Lymphoma,2017,NCI,2R01CA047006-30,,Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation,"ZHAO, BO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$532,500"
Lymphoma,2017,NHLBI,2UG1HL108945-07,,Targeting HIV and EBV Antigens in Patients with HIV Lymphoma,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$198,339"
Lymphoma,2017,NCI,3R01CA168482-05S1,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$84,395"
Lymphoma,2017,NHLBI,2UG1HL069315-17,,MSKCC BMT CTN Renewal,"PERALES, MIGUEL-ANGEL",SLOAN-KETTERING INST CAN RESEARCH,NY,"$193,800"
Lymphoma,2017,NCI,1K99CA212302-01A1,,Resistance To Targeted Immunotherapies:CART19 as a Paradigm,"RUELLA, MARCO",UNIVERSITY OF PENNSYLVANIA,PA,"$174,096"
Lymphoma,2017,NCI,1R21CA220475-01,,PDL1 expression on B cells: a potential marker of pre-tumor cells in AIDS-NHL,"EPELDEGUI, MARTA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$202,275"
Lymphoma,2017,NCATS,1UH2TR002090-01,,Preclinical Evaluation of Vorinostat in Alopecia Areata,"CHRISTIANO, ANGELA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$319,999"
Lymphoma,2017,NCI,3P01CA100730-13S1,,Retrovirus Models of Cancer,"GREEN, PATRICK",OHIO STATE UNIVERSITY,OH,"$50,560"
Lymphoma,2017,NCI,3R01CA137488-22S1,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$195,580"
Lymphoma,2017,NCI,3R01CA187109-03S1,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$44,636"
Lymphoma,2017,NHLBI,1F31HL135986-01A1,,Identification of a novel population of hematopoietic precursor cells,"KOENIG, ANDREW",CINCINNATI CHILDRENS HOSP MED CTR,OH,"$36,504"
Lymphoma,2017,NCI,1F31CA220854-01,,Elucidating the role of the CXCL13/CXCR5 signaling axis in Angioimmunoblastic T-Cell Lymphoma (AITL),"ROSENBERG, ERIC",YALE UNIVERSITY,CT,"$28,755"
Lymphoma,2017,NCI,1F31CA221012-01,,"Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma","ANDREWS, JARED",WASHINGTON UNIVERSITY,MO,"$29,954"
Lymphoma,2017,NCI,1F30CA221250-01,,A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles,"SCHNORENBERG, MATHEW",UNIVERSITY OF CHICAGO,IL,"$49,044"
Lymphoma,2017,NCI,1F31CA220981-01,,Use of chromatin accessibility maps to discover novel regulatory circuits in aggressive B cell lymphomas,"DOANE, ASHLEY",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$44,044"
Lymphoma,2017,NCI,1F31CA220985-01,,Investigating Bruton's Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma,"TANG, SARAH",SLOAN-KETTERING INST CAN RESEARCH,NY,"$44,044"
Lymphoma,2017,NCI,1R01CA214890-01A1,,Vitamin D and Follicular Lymphoma,"FRIEDBERG, JONATHAN",UNIVERSITY OF ROCHESTER,NY,"$702,185"
Lymphoma,2017,NCI,1R01CA214131-01A1,,Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1,"CHOI, YOUNG BONG",JOHNS HOPKINS UNIVERSITY,MD,"$351,741"
Lymphoma,2017,NCI,2R44CA210841-02,,Precision quality check of immunotherapeutics via single-cell cytokine mapping,"ZHOU, JING","ISOPLEXIS, INC.",DE,"$974,208"
Lymphoma,2017,NIDCR,1R15DE027314-01,,LIMD1 Is a Novel Marker Associated with IRF4 in EBV Latency and Lymphoma,"NING, SHUNBIN",EAST TENNESSEE STATE UNIVERSITY,TN,"$444,000"
Lymphoma,2017,NCI,1R01CA221521-01,,NFAT activation in kGPCR tumorigenesis,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$377,438"
Lymphoma,2017,NIDCR,4R00DE024969-03,,Factors Influencing KSHV Infection and Spread within the Oral Cavity,"TOTONCHY, JENNIFER",CHAPMAN UNIVERSITY,CA,"$249,000"
Lymphoma,2017,NCI,261200800001E-111-0-35,,Genotyping for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$2,623,215"
Lymphoma,2017,NCI,261200800001E-111-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$1,380,084"
Lymphoma,2017,NCI,261200800001E-111-0-51,,DCTD Biopharmaceutical Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$5,855,121"
Lymphoma,2017,NCI,261200800001E-111-0-142,,OCG Data Coordinating Center,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$525,000"
Lymphoma,2017,NCI,1K23CA222659-01,,Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Effect,"DE OLIVEIRA, SATIRO",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$183,924"
Lymphoma,2017,NCI,1F99CA222742-01,,Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors,"WILLIAMS, ANNALYNN",UNIVERSITY OF ROCHESTER,NY,"$35,290"
Lymphoma,2017,NCI,1F99CA222750-01,,Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell Level,"FAN, JEAN",HARVARD UNIVERSITY,MA,"$33,667"
Lymphoma,2017,NIAID,2R01AI032524-26,,Mechanism and Targeting of V(D)J Recombination,"SCHATZ, DAVID",YALE UNIVERSITY,CT,"$439,551"
Lymphoma,2017,NCI,3P01CA206978-01S1,,Comprehensive dissection of the CLL genome and phenome to improve patient outcomes,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$132,000"
Lymphoma,2017,NCI,1U01CA224153-01,,Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches,"LONDON, CHERYL",TUFTS UNIVERSITY BOSTON,MA,"$1,745,768"
Lymphoma,2017,NIMHD,1R21MD011439-01A1,,Using epigenomic subtyping to understand the racial differences in lymphoma,"CHIU, BRIAN",UNIVERSITY OF CHICAGO,IL,"$254,325"
Lymphoma,2017,NIAID,1R01AI130152-01A1,,Regulation of Normal and Pathogenic B Cell Proliferation by a c-Myc-initiated Transcription Factor Cascade,"EGAWA, TAKESHI",WASHINGTON UNIVERSITY,MO,"$471,521"
Lymphoma,2017,NCI,3R01CA086065-18S1,,"HSC Diversity, in aging, ontogeny, and transformation","WEISSMAN, IRVING",STANFORD UNIVERSITY,CA,"$105,661"
Lymphoma,2017,NCI,7R01CA157644-08,,Targeted activation of autoimmune checkpoints in B cell malignancies,"MÜSCHEN, MARKUS",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$410,875"
Lymphoma,2017,NCI,3P01CA100730-14S1,,Retrovirus Models of Cancer,"GREEN, PATRICK",OHIO STATE UNIVERSITY,OH,"$109,098"
Lymphoma,2017,NCI,3R01CA158323-05S2,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$51,254"
Lymphoma,2017,NCI,3R01CA187109-04S1,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$113,565"
Lymphoma,2017,NCI,3R01CA187040-05S1,,Targeting SIRT1 in Mantle Cell Lymphoma,"SETO, EDWARD",GEORGE WASHINGTON UNIVERSITY,DC,"$94,835"
Lymphoma,2017,NCI,4R44CA183316-02,,A Phase I trial combining IV fenretinide and IV safingol to target overproduction,"SIMPSON, WILLIAM","CERRX, INC.",TX,"$648,029"
Lymphoma,2017,NCI,3R01CA154674-06S2,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$75,000"
Lymphoma,2017,NCI,4R00CA187192-03,,Ultrasensitive Quantitation of Circulating Tumor DNA,"NEWMAN, AARON",STANFORD UNIVERSITY,CA,"$249,000"
Lymphoma,2017,NCI,7R01CA180758-05,,KSHV interactions with host inflammasome components,"CHANDRAN, BALA",UNIVERSITY OF SOUTH FLORIDA,FL,"$257,233"
Lymphoma,2017,NCI,7F30CA189433-04,,Investigating the function of MTBP in lymphoma,"PUCCETTI, MATTHEW",THOMAS JEFFERSON UNIVERSITY,PA,"$42,909"
Lymphoma,2017,NCI,7K24CA201524-03,,Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era,"BLUM, KRISTIE",EMORY UNIVERSITY,GA,"$177,298"
Lymphoma,2017,NCI,3P50CA107399-10S1,,City of Hope Lymphoma SPORE,"FORMAN, STEPHEN",BECKMAN RESEARCH INSTITUTE/CITY OF HOPE,CA,"$300,000"
Lymphoma,2017,NCI,7K08CA208013-02,,Oncogenic programs driven by notch signaling in B-cell lymphoma,"RYAN, RUSSELL",UNIVERSITY OF MICHIGAN,MI,"$165,564"
Lymphoma,2017,NCI,7F30CA186458-04,,High-resolution analysis of chromatin regulation by the Max network,"KASINATHAN, SIVAKANTHAN",UNIVERSITY OF WASHINGTON,WA,"$49,044"
Lymphoma,2017,NCI,1ZIACP004410-41,,Family Studies,"TUCKER, MARGARET",NIH,,"$2,450,222"
Lymphoma,2017,NCI,1ZIACP005782-23,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$157,625"
Lymphoma,2017,NCI,1ZIACP010125-22,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,463,246"
Lymphoma,2017,NCI,1ZIACP010131-22,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON DE GONZALEZ, AMY",NIH,,"$4,206,471"
Lymphoma,2017,NCI,1ZIACP010150-18,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$566,530"
Lymphoma,2017,NCI,1ZIACP010170-17,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$630,447"
Lymphoma,2017,NCI,1ZIACP010176-17,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$1,010,365"
Lymphoma,2017,NCI,1ZIACP010183-15,,Descriptive Studies and Record Linkage,"ANDERSON, WILLIAM",NIH,,"$725,750"
Lymphoma,2017,NCI,1ZIACP010212-08,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$77,637"
Lymphoma,2017,NCATS,1ZIATR000047-03,,HTS enabled examination of drug combinations,"THOMAS, CRAIG",NIH,,"$205,360"
Lymphoma,2017,NCATS,1ZIATR000249-02,,"Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics","TAWA, GREGORY",NIH,,"$201,845"
Lymphoma,2017,NIDDK,1ZIADK036167-11,,Structural studies of sequential DNA cleavage by RAG1/RAG2 proteins in V(D)J recombination,"GELLERT, MARTIN",NIH,,"$2,648,477"
Lymphoma,2017,NCI,1ZIABC006198-28,,Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,"BURKE, TERRENCE",NIH,,"$796,553"
Lymphoma,2017,NCI,1ZIABC009287-33,,Cytokines and T Cell Development,"DURUM, SCOTT",NIH,,"$697,487"
Lymphoma,2017,NCI,1ZIABC009405-23,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$550,436"
Lymphoma,2017,NCI,1ZIABC010008-22,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$506,056"
Lymphoma,2017,NCI,1ZIABC010283-20,,DNA repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,645,808"
Lymphoma,2017,NCI,1ZIABC010304-19,,Biochemical Basis of T Cell Activation,"SAMELSON, LAWRENCE",NIH,,"$1,873,405"
Lymphoma,2017,NCI,1ZIABC010671-13,,Genetic Analysis of T-cell Differentiation,"BOSSELUT, REMY",NIH,,"$1,855,052"
Lymphoma,2017,NCI,1ZIABC010717-12,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$135,515"
Lymphoma,2017,NCI,1ZIABC010719-12,,Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$135,515"
Lymphoma,2017,NCI,1ZIABC010728-12,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$67,758"
Lymphoma,2017,NCI,1ZIABC010747-12,,Characterization of the Expression and Ligands of KIR3DS1,"MCVICAR, DANIEL",NIH,,"$242,437"
Lymphoma,2017,NCI,1ZIABC010885-10,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,287,015"
Lymphoma,2017,NCI,1ZIABC010888-10,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$865,406"
Lymphoma,2017,NCI,1ZIABC011006-10,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$1,226,826"
Lymphoma,2017,NCI,1ZIABC011007-10,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$1,226,826"
Lymphoma,2017,NCI,1ZIABC011008-10,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$1,226,826"
Lymphoma,2017,NCI,1ZIABC011010-10,,Oncogenic mechanisms and molecular targets in myeloma,"STAUDT, LOUIS",NIH,,"$245,365"
Lymphoma,2017,NCI,1ZIABC011065-10,,"Preclinical Testing of HDAC, mTOR and MYC Inhibitors","MOCK, BEVERLY",NIH,,"$695,826"
Lymphoma,2017,NCI,1ZIABC011070-10,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$914,053"
Lymphoma,2017,NCI,1ZIABC011219-09,,Combination Gene Therapy and Th1-Th2 Therapy,"FOWLER, DANIEL",NIH,,"$379,226"
Lymphoma,2017,NCI,1ZIABC011354-08,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$135,515"
Lymphoma,2017,NCI,1ZIABC011374-07,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$202,021"
Lymphoma,2017,NCI,1ZIABC011415-07,,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$18,908"
Lymphoma,2017,NCI,1ZIABC011417-07,,Improved Chimeric Antigen Receptor Therapies B-cell Malignancies,"KOCHENDERFER, JAMES",NIH,,"$359,253"
Lymphoma,2017,NCI,1ZIABC011427-06,,Immunohistochemical analysis of tumors,"BARR, FREDERIC",NIH,,"$1,745,892"
Lymphoma,2017,NCI,1ZIABC011471-06,,Cell-free assay technologies for the identification of active compounds,"OKEEFE, BARRY",NIH,,"$1,001,166"
Lymphoma,2017,NCI,1ZIABC011480-05,,Programming T Cell Fates for Therapeutic Use,"GATTINONI, LUCA",NIH,,"$1,374,247"
Lymphoma,2017,NCI,1ZIABC011511-05,,Chemical Targeting of Multi-Protein Complexes,"BERNAL, FEDERICO",NIH,,"$263,479"
Lymphoma,2017,NCI,1ZIABC011561-04,,Exploring mechanisms that govern immune homeostasis in skin,"NAGAO, KEISUKE",NIH,,"$650,508"
Lymphoma,2017,NCI,1ZIABC011654-03,,TEDDI-R in PCNSL,"WILSON, WYNDHAM",NIH,,"$203,271"
Lymphoma,2017,NCI,1ZIABC011660-03,,Development of fully-human anti-CD30 chimeric antigen receptors,"KOCHENDERFER, JAMES",NIH,,"$94,540"
Lymphoma,2017,NCI,1ZIABC011700-02,,Patient Oriented Research in Viral Malignancies and HIV-associated Cancers,"YARCHOAN, ROBERT",NIH,,"$77,563"
Lymphoma,2017,NCI,1ZIABC011772-01,,The role of Galpha13 signaling in suppression of lymphoma,"MUPPIDI, JAGAN",NIH,,"$1,597,365"
Lymphoma,2017,NCI,1ZIABC011780-01,,Clinical development of mechanism-based lymphoma therapies,"STAUDT, LOUIS",NIH,,"$981,462"
Lymphoma,2017,NCI,1ZIASC000550-37,,Lymphoma Disease Discovery and Definition,"JAFFE, ELAINE",NIH,,"$799,796"
Lymphoma,2017,NCI,1ZIASC004002-48,,IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,"WALDMANN, THOMAS",NIH,,"$1,524,881"
Lymphoma,2017,NCI,1ZIASC006741-25,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$677,573"
Lymphoma,2017,NCI,1ZIASC010288-20,,Th1-Th2 and Tc1-Tc2 T Cell Subsets in Transplantation Therapy,"FOWLER, DANIEL",NIH,,"$758,451"
Lymphoma,2017,NCI,1ZIASC010356-18,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$441,678"
Lymphoma,2017,NCI,1ZIASC010357-18,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,392,873"
Lymphoma,2017,NCI,1ZIASC010378-17,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$529,479"
Lymphoma,2017,NCI,1ZIBBC010906-10,,Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"WALDMANN, THOMAS",NIH,,"$2,710,901"
Lymphoma,2017,NCI,1ZICBC011029-10,,Preclinical development and clinical monitoring of adoptive immune therapy,"HAKIM, FRANCES",NIH,,"$585,861"
Lymphoma,2017,NCI,1ZICBC011079-10,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$2,164,058"
Lymphoma,2017,NCI,1ZICBC011093-10,,Flow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$234,279"
Lymphoma,2017,NCI,1ZICBC011104-10,,Flow Cytometric Evaluation of Biomarkers,"STETLER-STEVENSON, MARYALICE",NIH,,"$468,558"
Lymphoma,2017,NCI,1ZICSC006537-24,,Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,"FIGG, WILLIAM",NIH,,"$685,021"
Lymphoma,2017,NCI,1ZIDBC010963-10,,ETIB Clinical Research Core,"GRESS, RONALD",NIH,,"$2,833,484"
Lymphoma,2017,NCI,1ZIDBC010990-10,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$6,937,175"
Lymphoma,2017,NCI,1ZIDBC011317-08,,Dermatology Consultation Service,"COWEN, EDWARD",NIH,,"$352,392"
Lymphoma,2017,NCI,1ZIEBC010843-11,,Medical Oncology Fellowship Program,"BILUSIC, MARIJO",NIH,,"$5,848,926"
Lymphoma,2017,NCI,1ZIEBC011241-09,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$571,282"
Lymphoma,2017,NCI,1ZIGBC010856-11,,Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,"CUSTER, MARY",NIH,,"$20,183,433"
Lymphoma,2017,NCI,3P30CA086862-17S3,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$102,084"
Lymphoma,2017,NCI,3P30CA086862-17S4,,Cancer Center Support Grant (CCSG),"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$145,831"
Lymphoma,2017,NIAID,1ZIAAI000732-23,,"Clinical, Immunological and Genetic  Analyses of ALPS and Related Disordrs","RAO, VEMULKONDA",NIH,,"$79,140"
Lymphoma,2017,NIAID,1ZIAAI000733-23,,Enveloped Virus Glycoprotein/receptor Interactions,"BERGER, EDWARD",NIH,,"$289,060"
Lymphoma,2017,NIAID,1ZIAAI000858-18,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$385,949"
Lymphoma,2017,OD,3R01CA163217-07S1,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$236,852"
Lymphoma,2017,NIAID,1ZIAAI000913-16,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$854,802"
Lymphoma,2017,NIAID,1ZIAAI000978-12,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$427,401"
Lymphoma,2017,NIAID,1ZIAAI001024-11,,Molecular Regulation of B-Cell Differentiation and Function,"MORSE, HERBERT",NIH,,"$514,598"
Lymphoma,2017,NIAID,1ZIAAI001169-06,,"Transcriptional Regulation of Immune Cell Development, Activation and Functions","ZHU, JINFANG",NIH,,"$1,476,554"
Lymphoma,2017,NIAID,1ZIAAI001187-05,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$673,451"
Lymphoma,2017,NCI,4R00CA190861-03,,Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies,"OTT, CHRISTOPHER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$249,000"
Lymphoma,2017,NHLBI,1ZIAHL002346-13,,"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy","WIESTNER, ADRIAN",NIH,,"$1,624,315"
Lymphoma,2017,NHLBI,1ZIAHL005076-12,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$257,483"
Lymphoma,2017,NHLBI,1ZIAHL006070-08,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$804,816"
